BCR / ABL1 t(9;22) Fusion probe hybridized on patient material showing t(9;22) (q34;q11) reciprocal translocation (2RG1R1G). Image kindly provided by Monika Conchon, São Paulo.
BCR / ABL1 t(9;22) Fusion probe hybridized on patient material showing t(9;22) (q34;q11) reciprocal translocation (2RG1R1G). Image kindly provided by Monika Conchon, São Paulo.
IVD BCR/ABL1
The BCR/ABL1 t(9;22) Fusion FISH probe is optimized to detect the t(9;22)(q34;q11) reciprocal translocation in a dual-color, dual-fusion assay on metaphase/interphase spreads, blood smears and bone marrow cells. This probe will also detect cryptic insertions of ABL1 (previously known as ABL) into the BCR region not detectable by karyotyping and therefore described as Ph-negative.
References: Morris et al, 1990, Blood, 76; 1812-1818. Dewald et al, 1998, Blood, 91; 3357-3365. Kolomietz et al, 2001, Blood, 97; 3581-3588. Huntly et al, 2003, Blood, 102; 1160-1168. Tkachuk et al., 1990, Science, 250; 559-562.
产品
产品
KBI-10005
BCR/ABL1 t(9;22) Fusion
Product is out of stock
Due to manufacturing & supply chain issues, this product is currently unavailable. You may place your order and it will be fulfilled when the product is back in stock. For more help, please reach out to customer service at +1 844 534 2262 or nonurgentcs@leicabiosystems.com
Product is limited in stock
Product availability is limited, but products are in continuous production. Your order will be processed as normal and may take additional days to ship.
HK
